Genpharmasec is currently trading at Rs. 4.00, up by 0.07 points or 1.78% from its previous closing of Rs. 3.93 on the BSE.
The scrip opened at Rs. 4.32 and has touched a high and low of Rs. 4.32 and Rs. 3.54 respectively. So far 7515089 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 7.31 on 16-Jan-2024 and a 52 week low of Rs. 1.92 on 25-Jun-2024.
Last one week high and low of the scrip stood at Rs. 4.32 and Rs. 3.00 respectively. The current market cap of the company is Rs. 220.93 crore.
The promoters holding in the company stood at 29.98%, while Non-Institutions held 70.02% stake in the company
Genpharmasec has entered into a Supper stockist agreement with Amneal Healthcare (AHPL). In terms of this said Agreement, AHPL has agreed for Appointment of Genpharmasec as nonexclusive Supper Stockist within the territory to further sell to wholesale pharmacist and/or retail pharmacist the products which are manufactured by AHPL and its third-party contact manufacture or third-party licensors. AHPL undertakes to provide Genpharmasec with a minimum annual sales commitment of approximately Rs 60 crore for the period from January 1, 2025, to December 31, 2025.
Genpharmasec is an India-based company, which is engaged in pharmaceutical activities and trading in equity shares.
| Company Name | CMP |
|---|---|
| Redington | 216.55 |
| Adani Enterprises | 2286.65 |
| Amrapali Industries | 17.63 |
| Rashi Peripheral | 461.70 |
| PDS | 278.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: